Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is an increase over the number of companies cited in the previous month.
The citations in the county include:
- You offered food-producing animal(s) for interstate commerce that was found to bear or contain a drug residue in an edible tissue above an established safe level, safe concentration, or tolerance.
- You lack an adequate system to account for the drugs held for use in treating your food-producing animals.
- You did not keep, maintain complete and retain treatment records.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Noel D. Elmore | Veterinary | 09/11/2024 | Introduction/delivery into IS - illegal drug residue |
| Noel D. Elmore | Veterinary | 09/11/2024 | Drug inventory (control of drugs on premises) |
| Noel D. Elmore | Veterinary | 09/11/2024 | Record keeping |
Alerts Sign-up